N+1 Singer shares its H1 2018 Review

In our H1 review, we discuss the UK economic and equity market environment and notable transactions completed in the first half of 2018.

Thomson Reuters Analyst Awards 2018

We are delighted to announce that the N+1 Singer Life Sciences and Healthcare Team has been ranked ‘Top Earnings Estimator’ in Biotechnology for the Europe region for 2018.  The awards are globally recognised as the gold

Read More
Hipgnosis Songs Fund Ltd Publicly Lists on the Specialist Fund Segment

Today marks the first day of dealings for Hipgnosis Songs Fund Ltd, as they list on the Specialist Fund Segment on the Main Market on the London Stock Exchange.   Founded by Merck Mercuriadis, former manager

Read More
[Video] N+1 Singer’s Emerging Companies Lunch

Last Thursday we held our second ‘Emerging Companies Lunch’ hosted at The NED, in the City of London. Our private company lunches pair up fast-growing private companies with fund managers focused on small cap opportunities. For

Read More

Transaction Highlights

SDL

Date: July 2018

Sector: Software & IT Services   

Type: Acquisition


£36.2 million

Sanderson Group

Date: July 2018

Sector: Software & IT Services   

Type: Placing


£3.3 million

Itaconix

Date: July 2018

Sector: Chemicals  

Type: Placing


£4.4 million

Communications about our events, transactions and industries.